Trademark: 90534048
Status Date
Tuesday, October 31, 2023
Registration Number
7204292
Registration Date
Tuesday, October 31, 2023
Filing Date
Thursday, February 18, 2021
Published for Opposition
Tuesday, August 15, 2023
5 Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment or prevention of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements; Vaccines; Vaccines for the prophylaxis of viral diseases
1 Chemicals and biological preparations being biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes; Peptide carrier molecules for association with a biological macromolecule being biological preparations for use in the pharmaceutical industry; Peptidic carrier molecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry; Peptide carrier molecule in combination with a biological macromolecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry
44 Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
42 Scientific and technological services, namely, scientific research, analysis, and testing in the field of biological molecules, in particular for identification, testing and characterisation of biological molecules; scientific and technological services, namely, scientific pre-clinical and clinical testing of macromolecules in the field of biological molecules
Oct 31, 2023
Notice Of Registration Confirmation Emailed
Oct 31, 2023
Registered-Principal Register
Aug 15, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 15, 2023
Published For Opposition
Jul 26, 2023
Notification Of Notice Of Publication E-Mailed
Jul 13, 2023
Approved For Pub - Principal Register
Jun 20, 2023
Assigned To Examiner
Jun 8, 2023
Teas/Email Correspondence Entered
Jun 8, 2023
Correspondence Received In Law Office
Jun 8, 2023
Assigned To Lie
Mar 8, 2023
Automatic Update Of Assignment Of Ownership
Feb 21, 2023
Teas Response To Suspension Inquiry Received
Jan 11, 2023
Notification Of Inquiry As To Suspension E-Mailed
Jan 11, 2023
Inquiry To Suspension E-Mailed
Jan 11, 2023
Suspension Inquiry Written
Nov 30, 2022
Suspension Checked ¿ To Attorney For Action
Nov 28, 2022
Assigned To Examiner
Nov 21, 2022
Suspension Checked ¿ To Attorney For Action
Apr 8, 2022
Notification Of Letter Of Suspension E-Mailed
Apr 8, 2022
Letter Of Suspension E-Mailed
Apr 8, 2022
Suspension Letter Written
Mar 11, 2022
Teas/Email Correspondence Entered
Mar 10, 2022
Correspondence Received In Law Office
Mar 10, 2022
Teas Response To Office Action Received
Sep 16, 2021
Notification Of Non-Final Action E-Mailed
Sep 16, 2021
Non-Final Action E-Mailed
Sep 16, 2021
Non-Final Action Written
Sep 13, 2021
Assigned To Examiner
May 20, 2021
New Application Office Supplied Data Entered
Feb 22, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
